Randomised clinical trial: the long‐term safety and tolerability of naloxegol in patients with pain and opioid‐induced constipation
Lynn R. Webster(Adherent Technologies (United States)), Mark Sostek(AstraZeneca (United States)), Ulysses Diva(Korean Red Cross), William D. Chey(University of Michigan–Ann Arbor), Jan Tack(KU Leuven), Jaakko Lappalainen(Wilmington University)
Cited by 116
Related Papers
Functional Bowel Disorders
|Gastroenterology|2006|4.8k
Bowel Disorders
|Gastroenterology|2016|2.8k
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k